NCT06195111View on ClinicalTrials.gov

A Real-world Study of Trifluridine/Tipiracil Containing Regimen for the Treatment of Patients With mCRC (REFLECT Study)

Not yet recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

March 1, 2027

Study Completion Date

December 31, 2027

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG

Trifluridine/Tipiracil

This a rospective observational study. There is no treatment allocation. Patients administered Trifluridine/Tipiracil by prescription

All Listed Sponsors

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT06195111 - A Real-world Study of Trifluridine/Tipiracil Containing Regimen for the Treatment of Patients With mCRC (REFLECT Study) | Biotech Hunter | Biotech Hunter